Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite

Amrita Madabushi1, Sibani Chakraborty, S Zoë Fisher

  • 1Department of Biochemistry and Molecular Biology, University of Florida, College of Medicine, Gainesville, FL 32610, USA.

Insights

Crystallization of Plasmepsin 4 (PmPM4) from Plasmodium malariae, an aspartic protease, was achieved with inhibitor AG1776. This structural study aims to develop new antimalarial drugs by understanding PmPM4

Area of Science:

  • Biochemistry
  • Structural Biology
  • Parasitology

Background:

  • Plasmepsin 4 (PmPM4) is an aspartic protease from Plasmodium malariae.
  • It is a member of the plasmepsin family, crucial for hemoglobin digestion in malaria parasites.

Purpose of the Study:

  • To obtain crystals of PmPM4 in complex with the small-molecule inhibitor AG1776.
  • To determine the crystal structure of PmPM4-AG1776 complex for antimalarial drug development.

Main Methods:

  • Crystallization of PmPM4-AG1776 complex using PEG 4000, ammonium sulfate, and sodium acetate buffer.
  • X-ray diffraction data collection under cryoconditions to 3.3 A resolution.
  • Crystal characterization: orthorhombic space group P2(1)2(1)2, unit-cell parameters provided.

Main Results:

  • Orthorhombic crystals of PmPM4-AG1776 were successfully grown and characterized.
  • X-ray diffraction data yielded a resolution of 3.3 A.
  • The crystal system is P2(1)2(1)2 with specific unit-cell parameters and two molecules per asymmetric unit.

Conclusions:

  • The structural elucidation of PmPM4 in complex with inhibitors is expected.
  • This research is vital for developing novel antimalarial therapeutic agents.
  • Understanding PmPM4 structure can lead to targeted drug design against malaria.

Related Concept Videos